Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 751,498
  • Shares Outstanding, K 229,816
  • Annual Sales, $ 2,914 M
  • Annual Income, $ -422,640 K
  • 60-Month Beta 1.42
  • Price/Sales 0.25
  • Price/Cash Flow 0.61
  • Price/Book N/A
Trade ENDP with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.11
  • Number of Estimates 7
  • High Estimate 0.13
  • Low Estimate 0.06
  • Prior Year 0.60
  • Growth Rate Est. (year over year) -81.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.72 +23.16%
on 09/11/20
3.52 -4.83%
on 09/25/20
+0.32 (+10.56%)
since 08/28/20
3-Month
2.71 +23.62%
on 08/24/20
4.18 -19.86%
on 07/07/20
-0.08 (-2.33%)
since 06/30/20
52-Week
2.08 +61.06%
on 03/18/20
7.10 -52.82%
on 02/25/20
+0.14 (+4.36%)
since 09/30/19

Most Recent Stories

More News
Endo Up on COVID-19 Vaccine Manufacturing Deal with Novavax

Endo (ENDP) and Novavax enter a manufacturing agreement for the latter's COVID-19 vaccine candidate, NVX-CoV2373.

ENDP : 3.37 (+3.06%)
JNJ : 149.10 (+1.39%)
MRNA : 72.99 (+3.50%)
NVAX : 112.03 (+3.78%)
Endo (ENDP) Surges: Stock Moves 8.4% Higher

Endo (ENDP) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

ENDP : 3.37 (+3.06%)
CTLT : 86.19 (+1.17%)
Novavax, Endo rise; Cavco, Occidental Petroleum fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:

ENDP : 3.37 (+3.06%)
OXY : 10.11 (+1.20%)
CLNY : 2.72 (+0.37%)
FLR : 9.14 (-0.98%)
KTOS : 19.56 (+0.51%)
NVAX : 112.03 (+3.78%)
CVCO : 183.20 (+2.31%)
AIR : 19.17 (+0.31%)
BioMarin Initiates Gene Therapy Study for Phenylketonuria

BioMarin (BMRN), a leader in the phenylketonuria segment, initiates development of its first gene therapy for treating the rare genetic enzyme deficiency disorder.

ENDP : 3.37 (+3.06%)
RDY : 69.81 (+1.69%)
BMRN : 77.36 (+1.79%)
HZNP : 78.43 (+0.35%)
Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate

, /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide...

NVAX : 112.03 (+3.78%)
ENDP : 3.37 (+3.06%)
Endo to Present Qwo™ (collagenase clostridium histolyticum-aaes) Data at Vegas Cosmetic Surgery & Aesthetic Dermatology (VCS)

, /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that it will present data relevant to the use of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate...

ENDP : 3.37 (+3.06%)
Global and Regional Specialty Generic Drugs Market Research 2018 Report | Growth Forecast 2026

Market Study Report, LLC's latest research report on 'Specialty Generic Drugs Market' delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market...

ENDP : 3.37 (+3.06%)
NVS : 87.09 (+0.06%)
PFE : 36.73 (+1.55%)
VRX.TO : 30.80 (-3.33%)
Endo to Participate at Citi 15th Annual BioPharma Virtual Conference

, /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that it will participate in the Citi 15th Annual BioPharma Virtual Conference being held , 2020.  Members of management will host...

ENDP : 3.37 (+3.06%)
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), today announced that Robert ("Bob") J. Cobuzzi Jr., Ph.D., who has served as a member of the Company's Board of Directors since...

DFFN : 0.8462 (+0.27%)
ENDP : 3.37 (+3.06%)
Endo (ENDP) Down 19.5% Since Last Earnings Report: Can It Rebound?

Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ENDP : 3.37 (+3.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Key Turning Points

2nd Resistance Point 3.42
1st Resistance Point 3.35
Last Price 3.37
1st Support Level 3.17
2nd Support Level 3.08

See More

52-Week High 7.10
Fibonacci 61.8% 5.18
Fibonacci 50% 4.59
Fibonacci 38.2% 4.00
Last Price 3.37
52-Week Low 2.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar